# Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis

> **NCT06409572** · — · NOT_YET_RECRUITING · sponsor: **Sohag University** · enrollment: 80 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DIAGNOSTIC_TEST:** GeneXpert MTB/RIF

## Key facts

- **NCT ID:** NCT06409572
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409572, "Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06409572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*